Neurologic Events Following Diphtheria-Tetanus-Pertussis Immunization
1 From the Department of Epidemiology, Harvard School of Public Health, Boston, the Boston Collaborative Drug Surveillance Program, Boston University Medical Center, Waltham, Massachusetts, and the Group Health Cooperative of Puget Sound, Seattle
The frequency of serious neurologic events following the administration of 106,000 doses of diphtheria-tetanus-pertussis vaccine at Group Health Cooperative of Puget Sound was determined using a population-based case-control study with disease ascertainment through pharmacy and hospitalization records. There were no cases of acute unexplained encephalopathies in close temporal relation to vaccination. There was the new onset of one serious seizure disorder in the three days following immunization, with 1.13 expected on the basis of chance alone.
Key Words: diphtheria-tetanus-pertussis vaccine seizure infantile spasm encephalopathy
Submitted on February 25, 1987
Accepted on June 23, 1987
This article has been cited by other articles:
![]() |
S. Mattoo and J. D. Cherry Molecular Pathogenesis, Epidemiology, and Clinical Manifestations of Respiratory Infections Due to Bordetella pertussis and Other Bordetella Subspecies Clin. Microbiol. Rev., April 1, 2005; 18(2): 326 - 382. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Le Saux, N. J. Barrowman, D. L. Moore, S. Whiting, D. Scheifele, S. Halperin, and for Members of the Canadian Paediatric Society/ He Decrease in Hospital Admissions for Febrile Seizures and Reports of Hypotonic-Hyporesponsive Episodes Presenting to Hospital Emergency Departments Since Switching to Acellular Pertussis Vaccine in Canada: A Report From IMPACT Pediatrics, November 1, 2003; 112(5): e348 - 348. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Greene Vaccination Fears: What the School Nurse Can Do The Journal of School Nursing, October 1, 2002; 18(4_suppl): 31 - 35. [Full Text] [PDF] |
||||
![]() |
W. E. Barlow, R. L. Davis, J. W. Glasser, P. H. Rhodes, R. S. Thompson, J. P. Mullooly, S. B. Black, H. R. Shinefield, J. I. Ward, S. M. Marcy, et al. The Risk of Seizures after Receipt of Whole-Cell Pertussis or Measles, Mumps, and Rubella Vaccine N. Engl. J. Med., August 30, 2001; 345(9): 656 - 661. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. S. DuVernoy, M. M. Braun, and the VAERS Working Group Hypotonic-Hyporesponsive Episodes Reported to the Vaccine Adverse Event Reporting System (VAERS), 1996-1998 Pediatrics, October 1, 2000; 106(4): 52e - 52. [Abstract] [Full Text] |
||||
![]() |
R. T. Chen, J. W. Glasser, P. H. Rhodes, R. L. Davis, W. E. Barlow, R. S. Thompson, J. P. Mullooly, S. B. Black, H. R. Shinefield, C. M. Vadheim, et al. Vaccine Safety Datalink Project: A New Tool for Improving Vaccine Safety Monitoring in the United States Pediatrics, June 1, 1997; 99(6): 765 - 773. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Leviton Neurologic Sequelae of Pertussis Immunization- 1989 J Child Neurol, October 1, 1989; 4(4): 311 - 314. [PDF] |
||||









